FY27 Revenue Growth: Small Single-Digit
Management significantly cut full-year guidance citing continued monsoon uncertainty and weak demand environment. The company expects only modest growth despite prior expectations.
Dhanuka Agritech · forward-looking guidance across the available source record.
Guidance tracker
Management significantly cut full-year guidance citing continued monsoon uncertainty and weak demand environment. The company expects only modest growth despite prior expectations.
Despite Q1 achieving ₹26 crore, full-year Dahanu guidance is ₹65 crore. EBITDA break-even remains difficult with expected loss of ~₹45 crore for the year.
The new 23,000 MT formulation plant in Nagpur (Butibori industrial area) will incur ~₹100+ crore capex in FY27-28, targeting commissioning by April 2028 with automation and global safety standards.
Pipeline includes 1 liquid fertilizer, 3 fungicides, and 1 herbicide. Additionally, 3 biological products being launched (2 already introduced, 3rd by August end) plus 2 more nutrition biologicals in FY27.
Management expects full-year revenue to be flattish YoY, with Q4 showing growth but not enough to offset earlier declines.
Management expects full-year EBITDA margin to decline by 100-110 basis points compared to FY25.
The Dahej plant is expected to achieve 80% capacity utilization in FY27 with three products (bifenthrin, defenoconazole, and a new product).
Dhanuka plans to launch three new products in FY27, including two fungicides (first-time introductions) and a spray efficiency enhancer.